Pedro Vellosa Schwartzmann

Statistics

Publications

Citations

347

H-Index

Active since

2017

Affiliations

Clinics Hospital of Ribeirão Preto(Current)

Universidade de São Paulo

Vita-Salute San Raffaele University

Universidade do Estado do Rio de Janeiro

Université de Lorraine

Pedro Vellosa Schwartzmann is an author at Clinics Hospital of Ribeirão Preto specializing in medicine, cardiology, and heart failure pharmacotherapy.

ORCID

Publications per year

2017–2025

Publications

Zika Virus Meningoencephalitis in an Immunocompromised Patient

Pedro Vellosa Schwartzmann, Leandra Náira Zambelli Ramalho, Luciano Neder et al. · Mayo Clinic Proceedings · 2017 · 77 citations · Full text

Medicine, Infectious Diseases, Microbiology +14

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

A normal sodium diet preserves serum sodium levels during treatment of acute decompensated heart failure: A prospective, blind and randomized trial

Camila Godoy Fabricio, Denise Mayumi Tanaka, Jaqueline Rodrigues de Souza Gentil et al. · Clinical Nutrition ESPEN · 2019 · 30 citations

Medicine, Cardiology, Nutritional Sciences +13

Safety and tolerability of β-blockers: importance of cardioselectivity

Hans‐Peter Marti, Abel Alberto Pavía López, Pedro Vellosa Schwartzmann · Current Medical Research and Opinion · 2024 · 26 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–5 of 12